What are the definitive corrective procedures for symptomatic myocardial bridging?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Surgical Unroofing (Supra-Arterial Myotomy) is the Definitive Corrective Procedure for Symptomatic Myocardial Bridging

For symptomatic myocardial bridging refractory to medical therapy, surgical unroofing (supra-arterial myotomy) is the recommended definitive corrective procedure 1. This involves surgically opening the myocardial muscle overlying the tunneled coronary segment to relieve compression.

Treatment Algorithm

First-Line: Medical Management

  • Beta-blockers are the primary medical therapy for symptomatic myocardial bridging, as they reduce heart rate and myocardial contractility, thereby decreasing systolic compression 1, 2
  • Non-dihydropyridine calcium channel blockers (e.g., diltiazem) are effective alternatives or adjuncts, with demonstrated symptom resolution in clinical cases 2
  • Additional agents include ranolazine and ivabradine 3
  • Avoid nitrates - they paradoxically worsen symptoms by increasing angiographic systolic narrowing 4, 3

Surgical Intervention: When Medical Therapy Fails

Supra-arterial myotomy ("unroofing") is the procedure of choice when:

  • Chest pain persists despite optimized medical therapy 1
  • Perfusion imaging demonstrates blunted flow reserve distal to the bridge 1
  • The patient has documented ischemia attributable to the bridge 5

Technical Considerations

  • CT angiography should be performed preoperatively to define the course and depth of the bridged segment, which is crucial for surgical planning 1
  • The procedure may be technically challenging depending on the depth of the tunneled segment 1
  • Long-term outcomes are favorable, with 10-year freedom from major adverse cardiac events of 83.9% for isolated myotomy 5

CABG: Generally NOT Recommended for Isolated Myocardial Bridging

Critical caveat: Coronary artery bypass grafting (CABG) is problematic for isolated myocardial bridging 3. A recent case report demonstrates that CABG may result in competitive flow with retrograde "to-and-fro" blood flow in the graft without actual perfusion of the distal vessel 3. The native vessel distal to the bridge often has adequate flow during diastole, causing graft failure.

CABG may be considered only when:

  • Myocardial bridging coexists with significant obstructive coronary disease in other vessels 5
  • The patient is undergoing surgical myectomy for hypertrophic cardiomyopathy and has concurrent bridging 1
  • There is concern for ventricular rupture with myotomy due to extensive bridging depth 3

However, even in these scenarios, combined supra-arterial myotomy with CABG to other vessels shows better outcomes (10-year MACE-free rate of 92.0%) than CABG alone 5.

Special Populations

In hypertrophic cardiomyopathy patients:

  • Myocardial bridging occurs in 40% of autopsy cases and 15% on angiography 1
  • When undergoing surgical myectomy, the decision to unroof the bridge should be individualized based on whether perfusion imaging shows blunted flow reserve 1
  • Combined procedures (myectomy + unroofing) can be performed safely 6

Key Pitfalls to Avoid

  1. Do not perform CABG for isolated myocardial bridging - competitive flow will likely cause graft failure 3
  2. Do not use nitrates - they worsen systolic compression 4
  3. Do not proceed to surgery without comprehensive preoperative assessment including stress testing, perfusion imaging, and CT angiography to confirm the bridge is causing ischemia 3
  4. Do not stent myocardial bridges - this is not mentioned as a recommended option in guidelines and carries risk of stent fracture, restenosis, and perforation

Summary of Surgical Options by Clinical Scenario

  • Isolated symptomatic MB, failed medical therapy: Supra-arterial myotomy 1, 5
  • MB + obstructive CAD in other vessels: Myotomy + CABG to other vessels 5
  • MB + hypertrophic cardiomyopathy requiring myectomy: Consider combined myectomy + unroofing if perfusion defect present 1, 6
  • MB + right ventricular outflow tract obstruction: Combined infundibular myectomy + coronary unroofing 6

The evidence consistently supports supra-arterial myotomy as the definitive corrective procedure, with excellent long-term outcomes when appropriately selected patients fail medical management.

Related Questions

What is the recommended management and treatment for myocardial bridging?
When is percutaneous coronary intervention (PCI) indicated for myocardial bridging, and what is the recommended management approach?
How should I manage palpitations in a 56-year-old man with non‑obstructive coronary artery disease and a 7 % ventricular ectopic burden who has not responded to beta‑blocker therapy?
What is the appropriate management for a patient with a 12 mm myocardial bridge in the mid left anterior descending artery?
How should a female patient with a short‑segment myocardial bridge of the proximal left anterior descending artery be managed?
What empiric antibiotics should be given for suspected community-acquired pneumonia, including considerations for β‑lactam allergy and Pseudomonas risk?
What is the antimicrobial coverage of piperacillin‑tazobactam (Tazocin)?
What is the appropriate medical management for a patient with mild‑to‑moderate mitral regurgitation, mild‑to‑moderate aortic regurgitation, and right‑ventricular systolic pressure greater than 60 mm Hg?
Should cefadroxil be taken with food or on an empty stomach?
Is Tazocin (piperacillin‑tazobactam) an appropriate empiric choice for an adult patient requiring broad‑spectrum coverage?
What are the possible causes of pulmonary hypertension in a patient with elevated right‑ventricular systolic pressure (>60 mm Hg) secondary to mild‑to‑moderate mitral regurgitation and mild‑to‑moderate aortic regurgitation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.